About Semaglutide
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Clinical trials demonstrate significant reductions in body weight and cardiovascular risk markers. It works by enhancing insulin secretion, suppressing glucagon, and reducing appetite.
Semaglutide & Cardiovascular Health
Semaglutide has been studied for cardiovascular outcomes in adults with overweight or obesity. See the TruthTides evidence library for graded study summaries and citations.
Content sourced from existing TruthTides clinical reference documentation. This is informational only. Consult a qualified physician.
Find a Semaglutide prescriber in Los Angeles
Browse qualified physicians who prescribe Semaglutide in the Los Angeles area, or search nationwide via telehealth.
Ask TruthSource AI
Ask anything about Semaglutide for Cardiovascular Health
Get a guardrailed, evidence-anchored answer from our clinical reference tool.
Open Reference ToolFind a Doctor
Search verified Semaglutide prescribers nationwide
Filter by peptide, location, and telehealth availability.
Open Physician FinderSemaglutide for Cardiovascular Health in Other Cities
This content is sourced from existing TruthTides clinical reference documentation. It does not constitute medical advice or treatment recommendations. Consult a qualified physician before starting any peptide therapy.